Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
TEVATEVA(TEVA) GlobeNewswire News Room·2024-11-02 03:05

IMPACT-TD Registry, the largest study evaluating holistic effects of tardive dyskinesia (TD), highlights that there is a high burden of TD on quality of life regardless of a person’s underlying mental health conditionRegistry revealed fewer patients with psychotic disorders (36%) received TD diagnoses compared to those with mood disorders (50%)Teva continues to further innovations in mental health and progress real-world data to improve treatment optimization TEL AVIV, Israel and PARSIPPANY, N.J., Nov. 01, ...